Pharmaceutical Industry

The Times' editorial board, which has long supported free-trade deals, sounded a note of caution Friday about the next one in the pipeline, the Trans-Pacific Partnership. "The Obama administration's goal has been to persuade its trading partners to move toward U.S. standards in these areas, which tend to be more demanding than their own," the board wrote. "But it's important that the deal not undermine carefully crafted U.S. policies by advancing only selected parts of U.S. law. So what should the public be looking for if and when the deal is completed? (Be patient -- a deal that once seemed imminent doesn't appear to be so close now, and the text may...

Related "Pharmaceutical Industry" Articles

The Times' editorial board, which has long supported free-trade deals, sounded a note of caution Friday about the next one in the pipeline, the Trans-Pacific Partnership.
"The Obama administration's goal has been to persuade its trading partners...

MannKind Corp.’s inhaled insulin drug Afrezza continued its slow launch in the second quarter of the year.
Sanofi, the French pharmaceutical company that’s selling Afrezza in a partnership agreement with MannKind, said it sold just $2.2 million of the...

Patrick Soon-Shiong — pharmaceutical entrepreneur, part owner of the Lakers and the wealthiest man in Los Angeles — just got a little richer.
The stock of Soon-Shiong's cancer treatment company, NantKwest Inc., surged 39% in its first day of trading...

There's one especially eye-catching number in a new report by Medicare actuaries about U.S. healthcare spending: 12.6%.
That's the leap in prescription drug spending last year over the year before. How sharp an increase is it? It was five times...

Pharmaceutical company Allergan has agreed to sell its generic drug unit to Teva Pharmaceutical Industries of Israel for $40.5 billion, a move that will enable Allergan to focus on branded drugs, including blockbuster wrinkle treatment Botox.
The...

Biotech giant Amgen Inc. received the approval of European regulators for a new drug that the Thousand Oaks company said is highly effective at reducing "bad" cholesterol, which is a significant risk factor for heart disease.
The European...

The House of Representatives overwhelmingly approved legislation Friday to speed approval of drugs and medical devices and boost funding for medical research, pushing forward a major overhaul of the federal government’s regulation of key parts of the...

A gusher of Obamacare money is fueling a merger frenzy in U.S. healthcare.The latest jolt came Thursday when Woodland Hills insurer Health Net Inc. agreed to be bought by Medicaid insurer Centene Corp. for $6.8 billion.And more billion-dollar deals are in...

Over the last year, one of Orange County's most prestigious companies has been through the wringer: a hostile takeover attempt, scrutiny by the national press, layoffs and an acquisition.
Allergan — the Botox maker that has been in Irvine since before...

In its continuing bid to drive trans fats from U.S. diets, the Food and Drug Administration said it is striking partially hydrogenated oils from the list of food additives it considers so safe that manufacturers may use them without special...

Many companies say they're already meeting Food and Drug Administration demands to get rid of artificial trans fats — three years ahead of the deadline.
The FDA on Tuesday unveiled new rules requiring companies to eliminate almost all partially...

California poultry giant Foster Farms has joined the flock of meat companies eschewing the use of antibiotics, pledging to eliminate all those used to combat infection in humans.
The company's promise comes ahead of Tuesday's White House forum on the use...

Federal regulators announced Thursday that Teva Pharmaceuticals Industries will pay $1.2 billion to settle charges that one of its subsidiaries illegally blocked the launch of low-cost generic versions of the blockbuster sleeping pill Provigil.The...

CVS Health will spend more than $10 billion to buy pharmacy services provider Omnicare and tap a growing target for prescription drug distribution: care for the elderly. The deal announced Thursday will give one of the nation's biggest pharmacy benefits...

MannKind Corp., the Valencia maker of inhaled insulin that had been battered on Wall Street this year, is finally getting some good news.
The company's stock has soared since an analyst released a report that offered a bright outlook for its inhaled...

Endo International will spend about $8.05 billion to acquire Par Pharmaceutical as it pushes further into the generic drug market.Endo CEO Rajiv De Silva said the deal will make Endo one of the top five generics companies as measured by U.S. sales.Endo,...

The California Supreme Court on Thursday revived a class-action lawsuit that accuses German pharmaceutical giant Bayer of paying another drug company to delay introducing a generic version of a Bayer antibiotic.The practice is known as “pay to delay”...

Early sales of MannKind Corp.'s new inhaled insulin drug were less than expected, and the Valencia company's stock skidded to near a one-year low.
French pharmaceutical company Sanofi, which is marketing the drug, Afrezza, in a partnership with...

The Food and Drug Administration has approved a Westlake Village company's injectable drug as a treatment to reduce double-chin fat in adults.
Kythera Biopharmaceuticals Inc. said in a news release that injections of the drug have been shown in...